NET ASSET VALUE – 30 November 2024

MARKN.

On the 30 November 2024 Flerie AB's Net Asset Value (NAV) was SEK 4,206 million and NAV per share was SEK 53.88.



Allocation of NAV
Share of portfolio companyFair value (MSEK)Part of NAV per share (SEK)Share of NAV
Product Development    
Prokarium42%4866.2311.6%
Xspray Pharma18%2693.446.4%
KAHR Medical31%2062.644.9%
Empros Pharma79%2042.624.9%
Atrogi37%1762.254.2%
Lipum57%1712.194.1%
Microbiotica11%1381.773.3%
Geneos Therapeutics12%1051.342.5%
Xintela56%1041.342.5%
Mendus24%1011.302.4%
Toleranzia66%971.252.3%
EpiEndo Pharmaceuticals9%570.731.4%
Synerkine Pharma43%530.681.3%
AnaCardio19%520.661.2%
Egetis Therapeutics2%380.490.9%
Buzzard Pharmaceuticals14%290.370.7%
Vitara Biomedical8%290.370.7%
Sixera Pharma24%270.350.6%
Alder Therapeutics21%170.220.4%
Amarna Therapeutics58%120.150.3%
Strike Pharma16%90.110.2%
Total 2,38030.4956.6%





Commercial Growth   
NorthX Biologics92%1892.424.5%
Symcel31%1692.164.0%
Provell Pharmaceuticals72%780.991.8%
Chromafora31%730.931.7%
Nanologica43%630.811.5%
A3P Biomedical8%420.541.0%
Frontier Biosolutions2%190.240.5%
Bohus Biotech45%170.210.4%
Total 6498.3115.4%





Limited Partnerships, total 921.182.2%
     
Assets related to Portfolio companies 2993.847.1%
Other assets and liabilities 78510.0618.7%
     
Net asset value 4,20653.88100.0%
  

 

    

* indirect shares in Provell Pharmaceuticals

Datum 2024-12-03, kl 08:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!